Entegris Reports First-Quarter Results Quarterly

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Entegris Reports First-Quarter Results
  • Quarterly revenue of $165.8 million, down 11 percent sequentially
  • GAAP net income of $14.3 million, or $0.10 per share; Non-GAAP net income of $16.7 million, or $0.12 per share
  • Operating margin of 11.2 percent; Adjusted operating margin of 13.4 percent

BILLERICA, Mass., April 23, 2014 (GLOBE NEWSWIRE) -- Entegris, Inc. (Nasdaq: ENTG ) today reported its financial results for the Company's first quarter ended March 29, 2014.

The Company recorded first-quarter sales of $165.8 million, which compared to $186.3 million in the fourth quarter of 2013 and $165.1 million in the first quarter a year ago. First-quarter operating margin was 11.2 percent, with adjusted operating margin of 13.4 percent, excluding amortization of intangible assets of $2.3 million and transaction-related cost associated with the acquisition of ATMI of $1.3 million. Net income for the first quarter was $14.3 million, or $0.10 per diluted share. Non-GAAP earnings per share of $0.12 in the first quarter of 2014 compared to $0.16 in the fourth quarter of 2013 and $0.13 in the first quarter of 2013. A reconciliation table of GAAP to non-GAAP earnings per share and operating margin is contained in this press release.

Bertrand Loy, president and chief executive officer, said: "As expected, our first-quarter sales declined from the strong fourth quarter reflecting seasonally slower trends and a mixed industry environment. On an operating basis, we performed well, achieving our target operating model and generating cash flow from operations in line with our plans. We remain very pleased with the quality and extent of our intensified partnerships and collaborations with the key technology leaders in the industry, which position us well as these leaders ramp their next-generation manufacturing process technologies."

Mr. Loy added: "We were pleased to note that ATMI shareholders voted overwhelmingly in favor of our acquisition of ATMI, and we expect to receive the remaining regulatory approval sometime around the end of April. We are excited about the prospects of the combination of Entegris and ATMI for our shareholders, customers, and employees."

Before any impact or transaction-related costs of the anticipated acquisition of ATMI, for the fiscal second quarter ending June 28, 2014 the Company expects sales of $165 million to $175 million, net income of $13 million to $18 million, and EPS between $0.09 to $0.13 per share. On a non-GAAP basis, EPS is expected to range from $0.10 to $0.14 per share, which reflects net income on a non-GAAP basis in the range of $14 million to $19 million, which is adjusted for expected amortization expense of $2.3 million or $0.01 per share.

First-Quarter Results Conference Call Details

Entegris will hold a conference call to discuss its results for the first quarter on Wednesday, April 23, 2014, at 10:00 a.m. Eastern Time. Participants should dial 1-719-325-4900 or toll-free 1-877-795-3599, referencing confirmation code 1009975. Participants are asked to dial in 5 to 10 minutes prior to the start of the call. A replay of the call will be available starting April 23 at 1:00 p.m. (ET) until June 6, 2014. The replay can be accessed by using passcode 1009975 after dialing 1-719-457-0820 or 1-888-203-1112. A live and on-demand webcast of the call can also be accessed from the investor relations section of Entegris' website at www.entegris.com .

About Entegris

Entegris is a leading provider of a wide range of products for purifying, protecting and transporting critical materials used in processing and manufacturing in the semiconductor and other high-technology industries. Entegris is ISO 9001 certified and has manufacturing, customer service and/or research facilities in the United States, China, France, Germany, Israel, Japan, Malaysia, Singapore, South Korea and Taiwan. Additional information can be found at www.entegris.com .

Non-GAAP Information

The Company's consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States (GAAP). Adjusted EBITDA and Adjusted Operating Income together with related measures thereof, and non-GAAP EPS, are considered "Non-GAAP financial measures" under the rules and regulations of the SEC. These financial measures are provided as a complement to financial measures provided in accordance with GAAP. We provide non-GAAP financial measures in order to better assess and reflect operating performance. Management believes the non-GAAP measures help indicate our baseline performance before certain gains, losses or other charges that may not be indicative of our business or future outlook. We believe these non-GAAP measures will aid investors' overall understanding of our results by providing a higher degree of transparency for certain expenses and providing a level of disclosure that will help investors understand how we plan and measure our business. The presentation of non-GAAP measures is not meant to be considered in isolation, as a substitute for, or superior to, financial measures or information provided in accordance with GAAP. The calculations of Adjusted EBITDA margin, Adjusted Operating Income, and non-GAAP EPS are included elsewhere in this release.

Forward-Looking Statements

Certain information contained in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current management expectations only as of the date of this press release, and involve substantial risks and uncertainties that could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements. Statements that include such words as "anticipate," "believe," "estimate," "expect," "forecast," "may," "will," "should" or the negative thereof and similar expressions as they relate to Entegris or our management are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. These risks include, but are not limited to, fluctuations in the market price of Entegris' stock, Entegris' future operating results, other acquisition and investment opportunities available to Entegris, general business and market conditions and other factors. Additional information concerning these and other risk factors may be found in previous financial press releases issued by Entegris and Entegris' periodic public filings with the Securities and Exchange Commission, including discussions appearing under the headings "Risks Relating to our Business and Industry," "Manufacturing Risks," "International Risks," and "Risks Related to Owning Our Securities" in Item 1A of our Annual Report on Form 10–K for the fiscal year ended December 31, 2013, as well as other matters and important factors disclosed previously and from time to time in the filings of Entegris with the U.S. Securities and Exchange Commission. Except as required under the federal securities laws and the rules and regulations of the Securities and Exchange Commission, we undertake no obligation to update publicly any forward-looking statements contained herein.

Entegris, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
 
  Three Months Ended
  March 29, 2014 March 30, 2013 December 31, 2013
Net sales $165,804 $165,070 $186,260
Cost of sales 94,452 97,942 106,876
Gross profit 71,352 67,128 79,384
Selling, general and administrative expenses 34,787 32,421 37,559
Engineering, research and development expenses 15,690 12,173 15,773
Amortization of intangible assets 2,336 2,287 2,358
Operating income  18,539 20,247 23,694
Other income, net (16) (1,348) (663)
Income before income taxes 18,555 21,595 24,357
Income tax expense 4,243 5,198 3,816
Net income $14,312 $16,397 $20,541
       
       
Basic net income per common share: $0.10 $0.12 $0.15
Diluted net income per common share: $0.10 $0.12 $0.15
       
Weighted average shares outstanding:      
Basic 138,927 139,025 138,615
Diluted 139,706 139,831 139,408
       
Entegris, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(In thousands)
(Unaudited)
 
  March 29, 2014 December 31, 2013
ASSETS    
Cash and cash equivalents $381,661 $384,426
Accounts receivable, net 109,049 101,873
Inventories 100,499 94,074
Deferred tax assets, deferred tax charges and refundable income taxes 14,595 20,844
Other current assets 10,255 11,088
Total current assets 616,059 612,305
     
Property, plant and equipment, net 189,010 186,440
     
Intangible assets 41,141 43,509
Deferred tax assets – non-current 12,041 12,039
Other assets 25,251 21,001
Total assets $883,502 $875,294
     
   
LIABILITIES AND SHAREHOLDERS' EQUITY    
Accounts payable $ 41,168 $38,396
Accrued liabilities 43,355 48,816
Income tax payable and deferred tax liabilities 6,316 10,373
Total current liabilities 90,839 97,585
     
Other liabilities 20,870 20,866
Shareholders' equity 771,793 756,843
Total liabilities and shareholders' equity $883,502 $875,294
 
Entegris, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
 
  Three Months Ended
  March 29, 2014 March 30, 2013
Operating activities:    
Net income  $14,312 $16,397
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 7,832 7,296
Amortization 2,336 2,287
Stock-based compensation expense 1,877 1,688
Other 843 2,043
Changes in operating assets and liabilities:    
Accounts receivable, net (7,217) (12,893)
Inventories (7,545) (3,758)
Accounts payable and accrued liabilities (3,554) (7,015)
Income taxes payable and refundable income taxes 2,012 318
Other 1,516 1,072
Net cash provided by operating activities 12,412 7,435
Investing activities:    
Acquisition of property and equipment (13,780) (16,140)
Proceeds from maturities of short-term investments -- 20,000
Other 395 12
Net cash (used in) provided by investing activities (13,385) 3,872
Financing activities:    
Issuance of common stock -- 4,873
Taxes paid related to net share settlement of equity awards (1,989) --
Repurchase and retirement of common stock -- (3,777)
Other 244 741
Net cash (used in) provided by financing activities (1,745) 1,837
Effect of exchange rate changes on cash (47) (4,717)
(Decrease) increase in cash and cash equivalents (2,765) 8,427
Cash and cash equivalents at beginning of period 384,426 330,419
Cash and cash equivalents at end of period $381,661 $338,846
 
Entegris, Inc. and Subsidiaries
Segment Information
(In thousands)
(Unaudited)
 
  Three Months Ended
Net sales March 29, 2014 March 30, 2013 December 31, 2013
Contamination Control Solutions $105,318 $103,961 $123,665
Microenvironments 42,791 44,132 45,680
Specialty Materials 17,695 16,977 16,915
Total net sales $165,804 $165,070 $186,260
   
  Three Months Ended
Segment profit March 29, 2014 March 30, 2013 December 31, 2013
Contamination Control Solutions $24,480 $22,078 $30,417
Microenvironments 7,837 9,325 8,413
Specialty Materials 1,913 2,216 970
Total segment profit 34,230 33,619 39,800
Amortization of intangibles (2,336) (2,287) (2,358)
Unallocated expenses (13,355) (11,085) (13,748)
Total operating income $18,539 $20,247 $23,694
 
Entegris, Inc. and Subsidiaries
Reconciliation of GAAP to Adjusted Operating Income and Adjusted EBITDA
(In thousands)
(Unaudited)
 
  Three Months Ended
  March 29, 2014 March 30, 2013 December 31, 2013
Net sales $165,804 $165,070 $186,260
Net income $14,312 $16,397 $20,541
Adjustments to net income:      
Income tax expense 4,243 5,198 3,816
Other income, net (16) (1,348) (663)
GAAP – Operating income 18,539 20,247 23,694
Amortization of intangible assets 2,336 2,287 2,358
Transaction-related costs 1,281  --  973
Adjusted operating income  22,156 22,534 27,025
Depreciation 7,832 7,296 7,656
Adjusted EBITDA $29,988 $29,830 $34,681
       
Adjusted operating margin 13.4% 13.7% 14.5%
Adjusted EBITDA – as a % of net sales 18.1% 18.1% 18.6%
 
Entegris, Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Earnings per Share
(In thousands)
(Unaudited)
  Three Months Ended
  March 29, 2014 March 30, 2013 December 31, 2013
GAAP net income $14,312 $16,397 $20,541
Adjustments to net income:      
Amortization of intangible assets 2,336 2,287 2,358
Transaction-related costs 1,281 -- 973
Reclassification of cumulative translation adjustment associated with liquidated subsidiary -- -- 48
Tax effect of adjustments to net income (1,279) (824) (1,180)
Non-GAAP net income $16,650 $17,860 $22,740
       
Diluted earnings per common share: $0.10 $0.12 $0.15
Effect of adjustments to net income 0.02 0.01 0.02
Diluted non-GAAP earnings per common share: $0.12 $0.13 $0.16

Steven Cantor VP of Corporate Relations T +1 978 436 6750

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Laboratoires Pierre Fabre and XtalPi Unite for AI-Driven Drug Hunt

Updated Category News Views 191

An Unexpected Turn in the Drug Discovery Arena It's not every day that you see a historic French pharma powerhouse and a cutting-edge Chinese tech firm join forces. On one side, we've got Laboratoires Pierre Fabre, steeped in the history and nitty-gritty of clinical drug development. On the other, we’ve got XtalPi Holdings Limited (2228.HK), bringing their high-tech AI...

Continue Reading
West Virginia's Water Upgrade: AWK's Strategic Moves

Updated Category News Views 6

Building a Water Infrastructure with Purpose Well, they ain't just whistling Dixie down in Ranson, West Virginia. American Water's been busy putting their money where their mouth is with this new 816,000-gallon tank. When you look at the bigger picture, it ain't just about a shiny new water storage toy. Nah, this is about setting the stage for long-term resilience in the...

Continue Reading
NAMSA, AMS Partner to Fast-Track Tissue-Healing Tech

Updated Category News Views 41

Streamlining the Path to Market I tell you, the medical device sector is no walk in the park these days. Between the regulators breathing down your neck and the endless red tape, getting a new product from the lab to the hospital floor can feel like running a marathon in quicksand. That's why this deal between NAMSA and Advanced Medical Solutions (AMS) has me taking a...

Continue Reading
Paratus Energy Lands Petrobras Tender, Ties Finalizing

Updated Category News Views 64

Seagems Joint Venture Snags Petrobras Contract Let’s dive headfirst into this business update, because this one's got teeth, folks. Petrobras, the big dog in Brazil’s oil arena, has given the green light to Seagems’ bid, a joint venture half-owned by Paratus Energy Services Ltd. The target? A hefty pipe-laying support vessel (PLSV) contract starting in 2028. But...

Continue Reading
KT&G Launches Heated Tobacco in Kazakhstan's Market

Updated Category News Views 99

KT&G Lights Up Kazakhstan In a bold move, KT&G is laying down the gauntlet in Kazakhstan's tobacco market, introducing its cutting-edge heated tobacco gizmo and a handful of sleek FAIIM sticks. Launching this October, these aren't just any devices—they're the FLEX locals have been waiting for, rebranded from South Korea's lil AIBLE and AIIM but made to fit right in with...

Continue Reading
Korean 'Glocal' Districts Entice U.S. Tourists with Local Flavor

Updated Category News Views 102

Gwangju's Dongmyeong-dong is like the neighborhood artists and hipsters flock to in New York—except it’s got a Korean twist. Nestled in the Jeonnam region, this place is hot on American tourists' radar for its spicy mix of local culture, unique eats, and shops that scream individuality. It's becoming a magnet for folks who want to get a taste of Korean life but with a...

Continue Reading
Middleby Under Scrutiny: Shareholder Investigation Alert

Updated Category News Views 10

Middleby Shareholders in the Crosshairs There's hot soup boiling over at The Middleby Corporation (NASDAQ: MIDD). A shareholder investigation is underway, spearheaded by Purcell & Lefkowitz LLP, a firm that jumps into the fray when there’s a whiff of fiduciary breaches in corporate dealings. As I see it, this kind of legal sniffing around often stirs the pot—raising...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 345

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
UAE Pioneers eATA Carnet System Beyond Europe

Updated Category News Views 139

Breaking Tradition with Digital Innovation Well, who would’ve thought? The UAE just leapt ahead in the trade game, becoming the first to roll out the eATA Carnet system beyond the cozy confines of Europe. This isn’t some run-of-the-mill tech rollout, folks. It’s a digital revolution in how temporary imports are handled—goodbye paper, hello efficiency! With this...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 353

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading

Top 5 Most Recently Viewed Articles

Cristcot Enhances Its Connection with GI Experts at Major Meeting

Updated Category News Views 265

Cristcot Strengthens Engagement with Gastrointestinal Experts Cristcot, a pioneering clinical-stage pharmaceutical company, is focused on advancing innovative therapies for gastrointestinal diseases. Recently, they participated in the GI ReConnect meeting as a Gold Sponsor, offering them a platform to connect with leading gastroenterologists and explore new avenues in GI...

Continue Reading
Singapore Investors Embrace Local Stocks with Renewed Growth

Updated Category News Views 208

Singapore Stocks: A Trusted Choice for Investors Recent insights from Moomoo Singapore reveal that local stocks continue to play a vital role in retail investors' portfolios, highlighting their importance in investment strategies. A significant majority of investors in Singapore view local stocks as essential, opting to maintain or increase their holdings in the near...

Continue Reading
LG's Bold 3D Display Advocates for Monarch Butterfly Conservation

Updated Category News Views 272

LG's Stunning Display for Wildlife Awareness LG Electronics is proudly showcasing its commitment to conservation with a remarkable 3D video display in Times Square. This campaign aims to spotlight the 'vulnerable' monarch butterfly, capturing the attention of millions and advocating for biodiversity and climate action. Highlighting the Monarch Butterfly The immersive...

Continue Reading
Stride Inc. Faces Securities Fraud Investigation Amid Concerns

Updated Category News Views 104

Understanding the Recent Allegations Against Stride Inc. Stride Inc. (NYSE: LRN) is currently under investigation for potential violations of securities law. The investigation has arisen after troubling allegations surfaced regarding the company's financial practices. Investors who have experienced losses in their investments in Stride, Inc. are encouraged to seek further...

Continue Reading
Phoenix Energy's IPO: A Major Step Towards Growth

Updated Category News Views 335

Phoenix Energy Closes Successful Preferred Share IPO Phoenix Energy One, LLC has made headlines by successfully closing its initial public offering (IPO) of Series A Cumulative Redeemable Preferred Shares. This significant event marks a milestone in the company’s growth trajectory, as it raised around $54 million through the sale of roughly 2.7 million Preferred Shares...

Continue Reading